Literature DB >> 16188588

Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator.

Arash Arya1, Majid Haghjoo, Mohammad Reza Dehghani, Mohammad Alasti, Hormoz Alizadeh, Babak Kazemi, Mohammad Ali Sadr-Ameli.   

Abstract

BACKGROUND: Cardiac resynchronization therapy (CRT) reduces mortality in selected patients with heart failure. However, this result may not be entirely related to the beneficial hemodynamic effects of CRT.
OBJECTIVES: The purpose of this study was to assess retrospectively the effect of CRT on the incidence of appropriate therapy in patients with an implantable cardioverter-defibrillator (ICD).
METHODS: Sixty-five patients (48 men and 17 women; mean age 58 +/- 13 years) with an ICD (31 biventricular, 34 dual-chamber) were included in the study. Clinical, ECG, and ICD stored data and electrograms were collected.
RESULTS: Biventricular and dual-chamber ICDs were implanted in 31 and 34 patients, respectively, who had either ischemic (n = 36) or dilated cardiomyopathy (n = 29). Thirty-two (49%) patients received > or =1 appropriate ICD therapy during follow-up of 11 +/- 8 months. Thirty-five percent and 62% of patients with biventricular (n = 11) and dual-chamber ICDs (n = 21), respectively, received appropriate ICD therapy during the follow-up period (odds ratio = 0.340, P = .048). Stratifying the patients according to underlying heart disease and ejection fraction resulted in an adjusted odds ratio = 0.239 (P = .029). Comparing the rate of > or =1 appropriate ICD therapy between the two groups by Kaplan-Meier analysis and the log rank test resulted in P = .027.
CONCLUSION: In this retrospective analysis, biventricular pacing was associated with a decreased incidence of sustained ventricular arrhythmias requiring ICD therapy. The antiarrhythmic effect of biventricular pacing could contribute to the reduction in mortality reported in recent large-scale clinical trials on CRT. However, further prospective studies are warranted to clarify this issue.

Entities:  

Mesh:

Year:  2005        PMID: 16188588     DOI: 10.1016/j.hrthm.2005.07.007

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  9 in total

Review 1.  The emerging role of cardiac resynchronization therapy in milder heart failure: are we implanting too late for response?

Authors:  Jason Bradfield; Noel G Boyle; Ravi Mandapati; Kalyanam Shivkumar
Journal:  Curr Heart Fail Rep       Date:  2012-03

Review 2.  Electrical remodeling in dyssynchrony and resynchronization.

Authors:  Takeshi Aiba; Gordon Tomaselli
Journal:  J Cardiovasc Transl Res       Date:  2012-01-21       Impact factor: 4.132

3.  Potential pro-arrhythmic effect of cardiac resynchronization therapy.

Authors:  Osama Tayeh; Waleed Farouk; Abdo Elazab; Hassan Khald; Antonio Curnis
Journal:  J Saudi Heart Assoc       Date:  2013-05-30

4.  Impact of left ventricular lead position on the incidence of ventricular arrhythmia and clinical outcome in patients with cardiac resynchronization therapy.

Authors:  Thomas Kleemann; Torsten Becker; Margit Strauss; Ngoc Dyck; Steffen Schneider; Udo Weisse; Werner Saggau; Bernd Cornelius; Günter Layer; Karlheinz Seidl
Journal:  J Interv Card Electrophysiol       Date:  2010-03-03       Impact factor: 1.900

5.  Effect of cardiac resynchronization therapy on the risk of ventricular tachyarrhythmias in patients with chronic kidney disease.

Authors:  Usama A Daimee; Yitschak Biton; Arthur J Moss; Wojciech Zareba; David Cannom; Helmut Klein; Scott Solomon; Martin H Ruwald; Scott McNitt; Bronislava Polonsky; Paul J Wang; Ilan Goldenberg; Valentina Kutyifa
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-09-15       Impact factor: 1.468

6.  Cardiac sympathetic denervation and mental health.

Authors:  Sahib S Khalsa; Ashley N Clausen; Leila Shahabi; Julie Sorg; Sarah E Gonzalez; Bruce Naliboff; Kalyanam Shivkumar; Olujimi A Ajijola
Journal:  Auton Neurosci       Date:  2021-02-14       Impact factor: 3.145

Review 7.  Cardiac resynchronization therapy in clinical practice: need for electrical, mechanical, clinical and logistic synchronization.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Cinzia Valzania; Matteo Ziacchi; Matteo Bertini; Salvatore Specchia; Francesco Grigioni; Claudio Rapezzi; Angelo Branzi
Journal:  J Interv Card Electrophysiol       Date:  2007-02-24       Impact factor: 1.759

8.  Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia.

Authors:  Christian Eickholt; Marcus Siekiera; Kiriakos Kirmanoglou; Astrid Rodenbeck; Nicole Heussen; Patrick Schauerte; Artur Lichtenberg; Jan Balzer; Tienush Rassaf; Stefan Perings; Malte Kelm; Dong-In Shin; Christian Meyer
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

9.  Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators.

Authors:  Mitsuharu Kawamura; Shuhei Arai; Kosuke Yoshikawa; Toshihiko Gokan; Ko Ogawa; Akinori Ochi; Yoshimi Onishi; Yumi Munetsugu; Hiroyuki Ito; Tatsuya Onuki; Youichi Kobayashi; Toshiro Shinke
Journal:  Clin Cardiol       Date:  2019-05-13       Impact factor: 2.882

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.